GENE ONLINE|News &
Opinion
Blog

Technology
Newly Discovered Immune Cells can Help Fight CNS Damage
2020-11-01
Novartis Expands Foothold in Gene Therapy With New Acquisition
2020-10-30
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
The Future of CRISPR: Three Areas The Nobel Prize Winning Tech Will Be Most Impactful
2020-10-25
New Cas9 Alternatives Give Mammoth Biosciences an Edge Over Other CRISPR companies
2020-10-25
CRISPR Therapeutics’ CAR-T Cell Therapy Registers Mixed Results in Cancer Trial
2020-10-23
Intellia Trials CRISPR Drug as Permanent Cure to Fatal Hereditary Disease
2020-10-21
CRISPR Technology in Disease Modelling and Drug Discovery
2020-10-21
Genentech Looks to Strengthen Drug Discovery by Collaborating With This Stanford Spinout
2020-10-21
Harvard Spinout Bags $1.8 Billion Worth Gene Therapy Deal with Roche
2020-10-15
Ionis’ Inhaled Antisense Medicine Could Signal Decline for Cystic Fibrosis Medical Devices
2020-10-15
A.D.A.M’s Regulatory Progress Takes 3D Printed Bones a Step Closer to Reality
2020-10-11
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
Scribe, Biogen Partner to Combat ALS using Nobel Prize-Winning CRISPR Technology
2020-10-08
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
1 11 12 13 14 15 22
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top